この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1999/6/81 分で読めます
Medical Devices; Draft Guidance for FDA Staff on Civil Money Penalty Policy; Availability
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing the availability of the draft guidance entitled ``Guidance for FDA Staff on Civil Money Penalty Policy.'' The civil money penalty (CMP) policy is intended for use by all FDA Regional and District Directors for the purpose of advising their field personnel when considering potential CMP recommendations under the Safe Medical Devices Act of 1990 (SMDA).
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →